Breaking News Instant updates and real-time market news.

ATRC

AtriCure

$19.99

-0.13 (-0.65%)

18:35
03/13/18
03/13
18:35
03/13/18
18:35

AtriCure to see accelerated revenue growth in FY20, says Piper Jaffray

Piper Jaffray analyst Matt O'Brien kept his Overweight rating and a $24 price target on AtriCure after hosing investor meetings with the company CFO. O'Brien says AtriCure is performing well amid "newer association guidelines and missionary work from the company", while its MIS business should support revenues this year. The analyst adds that progress on Converge study is also being made, with combined impact of these products leading to accelerated growth rates for AtriCure in 2020.

  • 14

    Mar

ATRC AtriCure
$19.99

-0.13 (-0.65%)

11/02/17
PIPR
11/02/17
NO CHANGE
Target $24
PIPR
Overweight
AtriCure weakness a buying opportunity, says Piper Jaffray
Piper Jaffray analyst Matt O'Brien recommends using the post-earnings weakness in shares of AtriCure as a buying opportunity. The lowered sales outlook is largely the result of a spillover of deferrals from physician disruptions and fires in California, O'Brien tells investors in a post-earnings research note. The analyst views the headwinds as transitory and believes AtriCure can reaccelerate growth into 2018. He lowered his price target for the shares to $24 from $26 and maintains an Overweight rating on the name.
12/10/17
PIPR
12/10/17
NO CHANGE
Target $24
PIPR
Overweight
Piper Jaffray remains bullish on AtriCure, sees potential acceleration in 2020
Piper Jaffray analyst Matt O'Brien notes that he hosted investor meeting with AtriCure's CFO Andy Wade. Looking longer-term, the analyst believes the results of the Converge trial and a sub-x Clip might result in accelerating growth starting in 2020, which he believes would push shares much higher. Consequently, O'Brien encourages investors to start or build positions in this "compelling franchise." He reiterates an Overweight rating and $24 price target on the shares.
01/08/18
PIPR
01/08/18
NO CHANGE
PIPR
Overweight
AtriCure guidance possibly conservative, says Piper Jaffray
Piper Jaffray analyst Matt O'Brien noted that the midpoint of AtriCure's 2018 revenue guidance is below the consensus estimate, but he believes management is being conservative, which he said they have been historically. The analyst, who remains confident in the stock's set up for 2018, would be buying shares today, he tells investors. O'Brien keeps an Overweight rating on AtriCure, which is up fractionally to $18.03 in afternoon trading.
02/13/18
NEED
02/13/18
NO CHANGE
NEED
Needham a buyer of Medical Technologies product makers on Amazon headlines
After The Wall Street Journal report claiming that Amazon (AMZN) is attempting to become a major hospital supplier, Needham analyst Mike Matson said that he believes the e-commerce giant has typically disrupted middlemen much more than manufacturers. The analyst, who thinks Amazon's model may work for "lower tech" products but is unlikely to work with "higher tech" products, would be a buyer of Medical Technologies product maker stocks if they are down on weakness related to the headline risk represented by Amazon. However, Matson notes that he believe that Cantel Medical (CMD), CONMED (CNMD), Medtronic (MDT), Stryker (SYK) and Teleflex (TFX) generate a portion of their sales from "lower tech" products. Other stocks in MedTech manufacturing include AtriCure (ATRI), Cardiovascular Systems (CSII), Hill-Rom (HRC), K2M Group (KTWO), Mazor Robotics (MZOR), Zimmer Biomet (ZBH), Boston Scientific (BSX), Globus Medical (GMED), NuVasive (NUVA) and Wright Medical (WMGI).

TODAY'S FREE FLY STORIES

FB

Facebook

$143.64

3.33 (2.37%)

, TWTR

Twitter

$33.73

0.31 (0.93%)

16:22
12/18/18
12/18
16:22
12/18/18
16:22
Hot Stocks
Trump claims Facebook, Twitter, Google 'so biased' towards Democrats »

U.S. President Donald…

FB

Facebook

$143.64

3.33 (2.37%)

TWTR

Twitter

$33.73

0.31 (0.93%)

GOOG

Alphabet

$1,028.79

11.19 (1.10%)

GOOGL

Alphabet Class A

$1,043.31

16.77 (1.63%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Mar

WIN

Windstream

$2.69

0.15 (5.91%)

16:21
12/18/18
12/18
16:21
12/18/18
16:21
Hot Stocks
Windstream sells fiber assets to Arvig in $49.5M cash deal, to sell $11M more »

Windstream announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MDR

McDermott

$6.68

-0.43 (-6.05%)

16:20
12/18/18
12/18
16:20
12/18/18
16:20
Hot Stocks
McDermott signs a lease for new headquarters »

McDermott International…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VIX

Volatility Index S&P 500 Options

$0.00

(0.00%)

16:20
12/18/18
12/18
16:20
12/18/18
16:20
Options
Closing CBOE SPX and VIX Index summary for December 18th »

The CBOE Volatility Index…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SIG

Signet Jewelers

$31.23

-0.25 (-0.79%)

16:20
12/18/18
12/18
16:20
12/18/18
16:20
Options
Calls lead puts 10:1 in Signet Jewelers with shares at multi-year lows »

Calls lead puts 10:1 in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MRCY

Mercury Systems

$48.42

0.29 (0.60%)

16:19
12/18/18
12/18
16:19
12/18/18
16:19
Hot Stocks
Mercury Systems receives $2.9M follow-on order for SAASM devices »

Mercury Systems announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LLY

Eli Lilly

$106.56

-1.8 (-1.66%)

, ADRO

Aduro Biotech

$2.49

-0.14 (-5.32%)

16:18
12/18/18
12/18
16:18
12/18/18
16:18
Hot Stocks
Eli Lilly, Aduro Biotech announce research collaboration, license agreement »

Eli Lilly and Company…

LLY

Eli Lilly

$106.56

-1.8 (-1.66%)

ADRO

Aduro Biotech

$2.49

-0.14 (-5.32%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Dec

ADSK

Autodesk

$130.56

3.22 (2.53%)

16:18
12/18/18
12/18
16:18
12/18/18
16:18
Initiation
Autodesk initiated  »

Autodesk initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Jan

PTC

PTC

$83.56

1.23 (1.49%)

16:18
12/18/18
12/18
16:18
12/18/18
16:18
Initiation
PTC initiated  »

PTC initiated with a Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ALKS

Alkermes

$31.83

-1.125 (-3.41%)

16:18
12/18/18
12/18
16:18
12/18/18
16:18
Downgrade
Alkermes rating change  »

Alkermes downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Dec

  • 31

    Jan

LNT

Alliant Energy

$43.91

-0.23 (-0.52%)

16:17
12/18/18
12/18
16:17
12/18/18
16:17
Hot Stocks
Alliant Energy to move its comon stock to Nasdaq »

Alliant Energy will be…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ANSS

Ansys

$150.10

3.71 (2.53%)

16:17
12/18/18
12/18
16:17
12/18/18
16:17
Initiation
Ansys initiated  »

Ansys initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Jan

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

16:17
12/18/18
12/18
16:17
12/18/18
16:17
Technical Analysis
NASDAQ market internals summary »

Volume was above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EQT

EQT Corporation

$18.87

-0.03 (-0.16%)

16:16
12/18/18
12/18
16:16
12/18/18
16:16
Periodicals
Rice brothers want CEO post at EQT, new board members, WSJ reports »

Toby and Derek Rice, two…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

16:16
12/18/18
12/18
16:16
12/18/18
16:16
Technical Analysis
NYSE market internals summary »

Volume was above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MTCH

Match Group

$41.98

0.93 (2.27%)

16:15
12/18/18
12/18
16:15
12/18/18
16:15
Initiation
Match Group initiated  »

Match Group initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

INAP

Internap

$3.99

-0.14 (-3.39%)

16:12
12/18/18
12/18
16:12
12/18/18
16:12
Earnings
Internap narrows FY18 revenue view to $320M-$324M from $320M-$330M »

Consensus $322,32M. Sees…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SSTI

ShotSpotter

$29.26

-0.02 (-0.07%)

16:12
12/18/18
12/18
16:12
12/18/18
16:12
Initiation
ShotSpotter initiated  »

ShotSpotter initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SCS

Steelcase

$14.28

0.11 (0.78%)

16:10
12/18/18
12/18
16:10
12/18/18
16:10
Earnings
Steelcase sees Q4 EPS 24c-28c, consensus 26c »

Sees Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Dec

UPS

UPS

$97.72

0.8 (0.83%)

, FDX

FedEx

$185.74

3.54 (1.94%)

16:09
12/18/18
12/18
16:09
12/18/18
16:09
Hot Stocks
FedEx slides after cutting outlook citing European weakness, UPS follows »

In after-hours trading,…

UPS

UPS

$97.72

0.8 (0.83%)

FDX

FedEx

$185.74

3.54 (1.94%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Dec

HTGM

HTG Molecular

$2.40

-0.3 (-11.11%)

16:09
12/18/18
12/18
16:09
12/18/18
16:09
Hot Stocks
HTG Molecular establishes French unit to support expanding growth »

HTG Molecular Diagnostics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

INAP

Internap

$3.98

-0.15 (-3.63%)

16:09
12/18/18
12/18
16:09
12/18/18
16:09
Earnings
Internap sees FY19 revenue $325M-$335M, consensus $340.09M »

Sees FY19 adjusted EBITDA…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HTGM

HTG Molecular

$2.40

-0.3 (-11.11%)

16:08
12/18/18
12/18
16:08
12/18/18
16:08
Hot Stocks
HTG Molecular establishes French unit to support expanding growth »

HTG Molecular Diagnostics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

REI

Ring Energy

$5.18

0.02 (0.39%)

16:08
12/18/18
12/18
16:08
12/18/18
16:08
Hot Stocks
Ring Energy provides update on Q4 operations »

Ring Energy provided an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SCS

Steelcase

$14.23

0.055 (0.39%)

16:07
12/18/18
12/18
16:07
12/18/18
16:07
Earnings
Steelcase reports Q3 adjusted EPS 36c, consensus 30c »

Reports Q3 revenue $901M,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Dec

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.